Navigating patients with head and neck cancer (HNC) through their care is a challenge. Most patients will present with locoregionally advanced disease and, on average, a 5-year survival rate of 65%; this survival rate has increased slightly since the 1970s, but has remained stagnant for the last decade.1 Most patients will require multimodality treatment, including surgery, radiotherapy, and/or chemotherapy. This treatment regiment, itself, produces complications in 30% to 50% of patients.2,3